Thirty-day COVID-19 mortality rates have declined since 2020 but remain comparable to or slightly higher than influenza A mortality rates in recent years.

A single dose of RBL shows treatment success and low readmission rates for patients hospitalized with recurrent CDI.

From 2016 to 2024, there was an increase in labor induction rates across all maternal age groups and across all 6 race and Hispanic origin groups.

A cord blood storage company is being sued by 2 states claiming it misled parents about the benefits of saving their newborn’s stem cells.

The FDA has warned a biotech company about claims that its bladder cancer drug could treat and prevent multiple types of cancer.

Long COVID significantly increases the hazard of Alzheimer disease–related mild cognitive impairment compared with recovered or COVID-negative adults.